| Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma (NCT02748304) | Fudan University | 2016-04-01 |
| Expanding Phase III Study of Tyroserleutide for Injection (NCT03516448) | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | 2016-03-24 |
| Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC) (NCT02702960) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-03-01 |
| Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma (NCT02730611) | Assistance Publique - Hôpitaux de Paris | 2016-03-01 |
| Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC (NCT02771405) | National Hepatology & Tropical Medicine Research Institute | 2016-03-01 |
| Resection+Highly Purified CTL Versus Resection Alone for HCC (NCT02709070) | Sun Yat-sen University | 2016-03-01 |
| First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer (NCT02716012) | Mina Alpha Limited | 2016-03-01 |
| Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study (NCT02702323) | Zhejiang Cancer Hospital | 2016-03-01 |
| A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies (NCT02572687) | Eli Lilly and Company | 2016-02-19 |
| Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function (NCT02626312) | M.D. Anderson Cancer Center | 2016-02-15 |
| Italian Study Of Validation Of Angiogenesis Polymorphisms In HCC Patients Treated With Sorafenib (NCT02786342) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2016-02-15 |
| Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611 (NCT02509507) | Amgen | 2016-02-05 |
| RFA+Highly-purified CTL vs. RFA Alone for Recurrent HCC (NCT02678013) | Ming Kuang | 2016-02-01 |
| Clinical Intervention Modelling, Planning and Proof for Ablation Cancer Treatment (NCT02745600) | University of Leipzig | 2016-02-01 |
| Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors (NCT02705105) | Kyowa Kirin, Inc. | 2016-02-01 |
| The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction (NCT03212625) | Korea University Guro Hospital | 2016-01-28 |
| A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma (NCT02460835) | University of Michigan Rogel Cancer Center | 2016-01-26 |
| Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction (NCT02649712) | Xuzhou Central Hospital | 2016-01-20 |
| Myeloid Derived Suppressor Cells Control by Signal Regulatory Protein-alpha: Investigation in Hepatocellular Carcinoma (NCT02868255) | Nantes University Hospital | 2016-01-03 |
| Effects of Antiviral Therapy on Patients With HBV-related HCC (NCT05406089) | First Affiliated Hospital Xi'an Jiaotong University | 2016-01-01 |
| No-touch RFA Versus Traditional RFA for Small Hepatocellular Carcinoma (NCT02830737) | Southwest Hospital, China | 2016-01-01 |
| Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) or Portal Vein Thrombosis (NCT02309788) | Guangxi Medical University | 2016-01-01 |
| Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma (NCT02729506) | King Faisal Specialist Hospital & Research Center | 2016-01-01 |
| Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC (NCT02472249) | University Health Network, Toronto | 2016-01-01 |
| The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial. (NCT03368651) | Sun Yat-sen University | 2016-01-01 |
| Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases (NCT02511522) | Canadian Cancer Trials Group | 2015-12-11 |
| An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular Carcinoma (NCT02576509) | Bristol-Myers Squibb | 2015-12-07 |
| Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma (NCT02616926) | First Affiliated Hospital, Sun Yat-Sen University | 2015-12-01 |
| Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma Patients (NCT02642913) | Memorial Sloan Kettering Cancer Center | 2015-12-01 |
| Evaluation of Performance of Automatic Fusion for Radiofrequency Ablation of Hepatocellular Carcinoma (NCT02705118) | JOON-IL CHOI | 2015-12-01 |
| Analysis of the Role of Hepatocyte SLAMF3 Receptor and Drug Resistance Proteins (MDR) in Resistance to Treatment With Sorafenib in CHC Patients (NCT03113604) | Centre Hospitalier Universitaire, Amiens | 2015-11-20 |
| Gut Microbiota in People With Hepatocellular Carcinoma (HCC) (NCT02599909) | National Cancer Institute (NCI) | 2015-11-06 |
| Hepatic Arteriography in Liver Cancer Diagnosis and Staging Applications (NCT02936856) | Guangxi Medical University | 2015-11-01 |
| Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor (NCT02562963) | Minghui Zhang | 2015-11-01 |
| A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma (NCT02460991) | Boston Scientific Corporation | 2015-11-01 |
| The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma (NCT01953406) | Seoul National University Hospital | 2015-11-01 |
| A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma (NCT02519348) | MedImmune LLC | 2015-10-19 |
| HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B (NCT03048123) | Sun Yat-sen University | 2015-10-01 |
| Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma (NCT02585479) | Guangxi Medical University | 2015-10-01 |
| The Effect of Telephone Counseling on the Compliance and Satisfaction for Advanced HCC Patients Receiving Sorafenib (NCT02564666) | Asan Medical Center | 2015-10-01 |
| Liver Fibrosis in Zambian HIV-HBV Co-infected Patients (NCT02344680) | University of Alabama at Birmingham | 2015-10-01 |
| A Study of Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma Patients (NCT02727309) | Peking University Cancer Hospital & Institute | 2015-10-01 |
| Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma (NCT02584556) | Guangxi Medical University | 2015-10-01 |
| Treatment for Patients With Multiple Hepatocellular Carcinomas Based on the NDR Scoring System (NCT02525952) | Eastern Hepatobiliary Surgery Hospital | 2015-10-01 |
| Safety and Efficacy of Doxorubicin-eluting-bead Embolization in Patients With Advanced Hepatocellular Carcinoma (NCT02525380) | Seoul National University Hospital | 2015-09-01 |
| Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma (NCT02534337) | Guangxi Medical University | 2015-09-01 |
| 11C-acetate for Treatment Response After Radiotherapy for HCC (NCT02549755) | Justin Sims | 2015-09-01 |
| Hepatocellular Carcinoma Recurrence and Anesthesia (NCT02643173) | Seoul National University Bundang Hospital | 2015-09-01 |
| Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma (NCT02527772) | Guangxi Medical University | 2015-09-01 |
| The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular Carcinoma (NCT02525965) | Eastern Hepatobiliary Surgery Hospital | 2015-08-01 |
| Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular Carcinoma (NCT02504983) | Chang Gung Memorial Hospital | 2015-08-01 |
| DEB-TACE for Hepatocellular Carcinoma (NCT02748161) | Surefire Medical, Inc. | 2015-08-01 |
| TACE With or Without Sorafenib in Intermediate Stage Hepatocellular Carcinoma (NCT02529761) | Air Force Military Medical University, China | 2015-08-01 |
| Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma (NCT02526043) | Fudan University | 2015-08-01 |
| CT/MR-US Automatic Fusion System in Pre-procedure Planning for Radiofrequency Ablation (NCT04844112) | Seoul National University Hospital | 2015-08-01 |
| Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI (NCT04891874) | Eastern Hepatobiliary Surgery Hospital | 2015-08-01 |
| Metabolic Signature of Healthy Lifestyle and HCC (NCT03356535) | International Agency for Research on Cancer | 2015-08-01 |
| Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection (NCT02537158) | Chinese Academy of Medical Sciences | 2015-08-01 |
| A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein (NCT02435433) | Eli Lilly and Company | 2015-07-20 |
| In Vitro Models of Liver and Pancreatic Cancer (NCT02436564) | Cambridge University Hospitals NHS Foundation Trust | 2015-07-01 |
| Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1 (NCT02129322) | Zhejiang University | 2015-07-01 |
| SBRT as Bridging Therapy for Hepatocellular Carcinoma Patients on Transplant Waitlist (NCT03950102) | The University of Hong Kong | 2015-07-01 |
| Correlation Between CT Perfusion and Post Y-90 TARE PET/CT Dosimetry (NCT02558205) | Rush University Medical Center | 2015-07-01 |
| Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients (NCT03007225) | Ain Shams University | 2015-07-01 |
| Molecular Basis of Pediatric Liver Cancer (NCT03959800) | University of Pittsburgh | 2015-06-22 |
| Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization (NCT02471313) | National Institutes of Health Clinical Center (CC) | 2015-06-12 |
| REgistry of Selective Internal Radiation Therapy in TaiwaN (RESIN) (NCT03292991) | Taipei Veterans General Hospital, Taiwan | 2015-06-09 |
| Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma (NCT02586285) | Eastern Hepatobiliary Surgery Hospital | 2015-06-01 |
| Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma (NCT02802124) | Shanghai Proton and Heavy Ion Center | 2015-06-01 |
| Laparoscopic Surgery Versus Radiofrequency Ablation for Recurrent HCC (NCT02535117) | Sun Yat-sen University | 2015-06-01 |
| Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma (NCT02981498) | Sun Yat-sen University | 2015-06-01 |
| Primary Prevention Hepatocellular Carcinoma by Metformin (NCT02319200) | Assistance Publique - Hôpitaux de Paris | 2015-06-01 |
| Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma (NCT04553458) | Sohag University | 2015-06-01 |
| Bipolar RFA Using Twin ICW Electrodes vs. Switching Monopolar RFA for Recurrent HCC (NCT03806218) | Seoul National University Hospital | 2015-05-16 |
| DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma (NCT02487017) | Shenzhen Hornetcorn Bio-technology Company, LTD | 2015-05-01 |
| The European NAFLD Registry (NCT04442334) | Newcastle University | 2015-05-01 |
| HR Combined With FOLFOX4 for HCC With PVTT (NCT02452853) | Sun Yat-sen University | 2015-05-01 |
| Surefire Catheter Versus Standard End-hole Microcatheter: A Pilot Study (NCT02446925) | Wright State University | 2015-05-01 |
| Epidemiologic Study of Hepatocellular Carcinoma in the US (NCT02358070) | Stanford University | 2015-04-01 |
| Quality of Life in Patients With Hepatocellular Carcinoma (NCT02420678) | Asan Medical Center | 2015-04-01 |
| A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours (NCT02423239) | e-Therapeutics PLC | 2015-04-01 |
| RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC (NCT02426450) | Sun Yat-sen University | 2015-04-01 |
| Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular Carcinoma (NCT02395523) | National Cancer Center, Korea | 2015-03-05 |
| Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome (NCT04792463) | Mohamed Abdel-Rahman | 2015-03-03 |
| Genetic Profiling of Liver Cancer in Patients Undergoing Liver Transplantation (NCT02412579) | Baylor Research Institute | 2015-03-01 |
| Simo Decoction and Gum Chewing for Bowel Activity (NCT02438436) | Guangxi Medical University | 2015-03-01 |
| Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC (NCT02670122) | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 2015-03-01 |
| A Study of BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular Carcinoma (NCT02354898) | Sumitomo Pharma Co., Ltd. | 2015-03-01 |
| Anti-GPC3 CAR T for Treating Patients With Advanced HCC (NCT02395250) | RenJi Hospital | 2015-03-01 |
| A Study of BBI608 Administrated With Sorafenib in Adult Patients With Advanced Hepatocellular Carcinoma (NCT02358395) | Sumitomo Pharma Co., Ltd. | 2015-02-01 |
| Volumetric Analysis of Hepatocellular Carcinoma After Transarterial Chemoembolization (NCT04780789) | Brno University Hospital | 2015-02-01 |
| A Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer (NCT02232633) | Sumitomo Pharma America, Inc. | 2015-02-01 |
| Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma (NCT02314052) | Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 2015-01-27 |
| Computer-assisted Tumor Ablation for Patients With Liver Cancer (NCT03630068) | Insel Gruppe AG, University Hospital Bern | 2015-01-01 |
| Prophylactic Antibiotics Before RFA for HCC (NCT02534961) | Taipei Veterans General Hospital, Taiwan | 2015-01-01 |
| Research and Application for New Clinical Diagnosis and Treatment System for HBV Related HCC Liver Transplantation (NCT06409507) | First People's Hospital of Hangzhou | 2015-01-01 |
| Circulating Tumor DNA Exposure in Peripheral Blood (NCT03517332) | Quantgene Inc. | 2015-01-01 |
| Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L (NCT02232490) | Immunitor LLC | 2015-01-01 |
| A Novel Laparoscopic Hepatectomy Posture, Left Lateral Position Plus Jackknife Position (NCT02809287) | Sun Yat-sen University | 2015-01-01 |
| Prognosis Analysis of Elderly Donor Liver in Liver Transplantation (NCT05355662) | First Affiliated Hospital Xi'an Jiaotong University | 2015-01-01 |